User login form 2012
sustainability in 12 sub-categories.
ROLLBACK and view CSR ratings
over time (pro level).
EXPORT customized search results
VIEW companies' CSR sites and
underlying data from many sources.
Discovers, develops, manufactures and commercializes biotherapeutics for unmet medical needs
The Swiss pharmaceutical conglomerate Hoffmann-La Roche now completely owns Genentech after completing its purchase on 26 March 2009 for approximately $46.8 billion. (Date: March 13, 2010)
Some material on this page has come from non-CSRHub sources.
Basic corporate social responsibility ratings
Data sources for this company
(unregistered users only see a sample of this list of sources)3 report(s) may be available
Subcategory CSR ratings
Special issues that affect this company
Original data values
(registered users can see the list, subscribers can see the data details for most sources)
Please register to see a list of flags for this company